SCHEMBL10089974

SCHEMBL10089974

Cc1cc(I)cc(C(=O)NCc2ccccc2OC(F)F)c1NC(=O)c1cc(Cn2nnc(C(F)(F)C(F)(F)F)n2)nn1-c1ncccc1Cl

nearest known ligand 0.41

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
HSD17B13 Q7Z5P4 3/20 0.34
MAPK8 P45983 1/20 0.33
DHODH Q02127 2/20 0.32
RIPK1 Q13546 4/20 0.31
EPHX2 P34913 3/20 0.31
LIPG Q9Y5X9 1/20 0.31
GPR6 P46095 1/20 0.31
TP53 P04637 1/20 0.31
MAPK1 P28482 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10090029 0.94 HSD17B13 (0.40) HSD17B13MAPK8RIPK1EPHX2
SCHEMBL10090045 0.90 NR1I2 (0.36) GPR6
SCHEMBL10089901 0.90 MAPK8 (0.34) HSD17B13MAPK8DHODHRIPK1EPHX2
SCHEMBL10089970 0.88 GPR6 (0.36) HSD17B13MAPK8DHODHEPHX2LIPG
SCHEMBL13085130 0.87 DHODH (0.33) DHODH
SCHEMBL13084847 0.87 DHODH (0.32) DHODH
SCHEMBL10089995 0.86 RIPK1 (0.38) RIPK1
SCHEMBL10090003 0.86 PDE2A (0.34) RIPK1EPHX2MAPK1
SCHEMBL13085200 0.85 DHODH (0.33) DHODH
SCHEMBL10089844 0.85 MAPK8 (0.35) HSD17B13MAPK8DHODHEPHX2LIPG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2582695-B1 ANTHRANILIC ACID DIAMIDE DERIVATIVES WITH CYCLICAL SIDE CHAINS BAYER IP GMBH (DE) 2015-09-30 EP disclosed
US-8791143-B2 Anthranilic diamide derivatives having cyclic side-chains BAYER CROPSCIENCE AG (DE) 2014-07-29 US disclosed
US-20120010249-A1 Anthranilic diamide derivatives having cyclic side-chains BAYER CROPSCIENCE AG (DE) 2012-01-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120010249-A1 Anthranilic diamide derivatives having cyclic side-chains DDT, ADCY1, ANTXR2 HSD17B13 4352/4885MAPK8 4028/4885DHODH 237/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.